Flow Cytometry System Market Outlook
The global flow cytometry system market was valued at USD 4,298.1 Million in 2019 and is projected to reach USD 9,452.6 Million by 2027, expanding at a CAGR of 10.0% during the forecast period. Flow cytometry is technique, which is used to measure the physical and chemical characteristics of cells.
Flow cytometry systems are the instruments, which are used for analyzing the quantitative of cells and for analyzing chromosomes, m-RNA, recombinant proteins, and other molecules, which are suspended in a fluid. Flow cytometry technique is based on the principle of the measurement of scattering of light by the particles. The fluorescence light is passed through the cell. The deflection of the light occurs, according to the complexity and size of the particle.
Forward-scattered light (FSC), and side-scattered light (SSC) are two methods of deflecting the light. The measurements of FSC and SSC are used for the differentiation of cell types in a heterogeneous cell suspension, while fluorescent markers are used for determining the proteins or nucleic acids. Fluorescence pattern of each cell suspension, which are mixed with FSC and SSC, can be used to identify the cells and to count their percentage.
For the detection of specific antibodies, cells are coated with fluorochrome-conjugated antibodies specific to the surface markers present on different cells. Flow cytometry techniques are used for identifying hematological malignancies. Cell size, granularity of the cell, and intracellular proteins can be identified using flow cytometry. Flow cytometry systems are used for precise analysis of small population of cells at high speed.
Flow Cytometry System Market Dynamics
Drivers
- Increased Use of Artificial Intelligence (AI) in Flow Cytometry Systems
The advent of new technology, has led to the adoption of the artificial intelligence (AI) for the detection and separation of the cells, molecules, and deoxyribonucleic acid (DNA), using a software, which is used in the flow cytometry systems process. AI is used in analyzing the images, and also interprets the complex data. Artificial intelligence uses programs and algorithms for the separation and analysis of cells.
AI, using the deep learning algorithms, simplifies the multimodal images, and reduces the variability in the data. The reduction in the variability in the data, enhances the quality of the data. The use of imaging flow cytometry systems combines brightfield, darkfield, and fluorescence-based detection all in one platform.
AI, finds its use in several applications, including, studies designed to monitor multiple subcellular compartments, or to locate and quantify the distribution of signaling molecules on, in, or between cells. Technological advancements and rise in the adoption of the AI in biotechnology and pharmaceutical industries are some of the factors, which boosts the adoption of AI in flow cytometry.
- Increase in Government Funding for Pharmaceutical and Biotechnology Companies
Governments are investing in research for the development of novel drugs and techniques for determining vaccines and drugs, thus boosting research and development (R&D) in the pharmaceutical and biotechnology industries. The investments boost the development of innovative products. Several research biotechnology and pharmaceutical companies have installed flow cytometers for the detection of recombinant proteins, and cell cycles.
Government investments reduce the burden on drug manufacturing companies, thus boosting the adoption of the flow cytometers. The government of the UK, has increased funding for R&D. The government is focusing on the development of new drugs for biosimilars and personalized medicines, which boost the adoption of flow cytometers for the determination of mechanism of action of the drugs.
Restrains
- High Costs of Flow Cytometry Systems
Flow cytometers are widely used in pharmaceutical and biotechnology companies, for the manufacturing of drugs. Flow cytometers are used for the monitoring of diseases and are used in the diagnostic centers and hospitals. High costs of the flow cytometers is one of the major factor, which hampers the demand for the flow cytometers. Large amount of capital is required for the purchase of the flow cytometers.
Several companies have funding limitations, which hampers the demand for the flow cytometers. Costs of the reagents, which are used for the detection of antibodies, are also high, which hampers the demand for the flow cytometers. These are some of the factors, which hinders the demand for the flow cytometers.
- Dearth of Skilled Professionals
Dearth of skilled personnel is one of the major factors which hampers the market. Flow Cytometry Systems requires qualified personnel for analysis of the molecules, during the flow cytometry process. Skilled personnel is required for the implementation of new techniques.
However, several people are unqualified or under skilled for the processes, thus hampering the market. Several workers are unaware of the process and this may have an impact on the final products. The dearth of skilled labors is among the major factor, which hampers the adoption of glow cytometers in research institutes and organizations.
Flow Cytometry System Market Segmental Outlook
On the basis of technology, the market is segmented into cell-based flow cytometry system, and bead- based flow cytometry systems. The cell-based flow cytometry systems accounted for 78.9% share of the market in 2019.
The rapid growth of the segment is attributed to the rise in the demand for the analysis of the cells, and identification of the cell population which are some of the factors, which contributes for the growth of the segment. Additionally, the cell-based flow cytometry system is widely available and convenient to use, which is one of the factors, which contributes for the growth of the market.
In terms of products and services, the global flow cytometry systems market is divided into reagents and consumables, instruments, services, software, and accessories. The instruments segment is sub-segmented into cell analyzers and cell sorters. Reagents, and consumables segment is anticipated to expand at a CAGR of 10.4% during the forecast period. Rise in the use of the reagents, and consumables, for the detection of the antibodies, which are some of the factors, which contributes for the demand for the reagents and consumables.
Based on applications, the global flow cytometry systems market is divided into research applications, immunology, clinical applications, and industrial applications. The research applications segment is further segregated into pharmaceutical and biotechnology, drug discovery, stem cell research, and in-vitro toxicity.
The pharmaceutical and biotechnology segment is anticipated to account for a significant share of the market during the forecast period, while the drug discovery segment is estimated to expand at a substantial CAGR during the forecast period.
Based on research applications, the market is segmented into cancer diagnostics, hematology, immunodeficiency diseases, organ transplantation, and other clinical applications. Cancer diagnostic segment is expected to have a significant share of the market, owing to the rise in the prevalence of cancer, which has led to the rise in the adoption of the flow cytometry systems for the prognosis of the diseases.
In terms of end-users, the global flow cytometry systems market is segregated into commercial organizations, hospitals, academic institutes, and clinical testing labs. The clinical testing labs segment is projected to constitute a large share of the market during the forecasts period, while the hospitals segment is anticipated to expand at significant pace during the forecast period.
Flow cytometry systems techniques is used for the analysis of the diseases. Flow cytometers are used to diagnose various types of cancer, which in turn, boost their adoption in the hospitals.
Flow Cytometry System Market Regional Outlook
In terms of regions, the global flow cytometry system market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the Asia Pacific is projected to expand at a CAGR of 10.9% during the forecast period. Rise in presence of several manufacturers, is thereby boosting the growth of the flow cytometry system market in Asia Pacific.
Key Benefits for Industry Participants & Stakeholders
- In-depth Analysis of the Global Flow cytometry system Market
- Historical, Current and Projected Market Size in terms of Value
- Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
- Industry Drivers, Restraints and Opportunities Covered in the Study
- Recent Industry Trends and Developments
- Competitive Landscape & Strategies of Key Players
- Neutral Perspective on Global Flow cytometry system Market Performance
Segments
By Technology
- Cell-based flow cytometry system
- Bead-based Flow cytometry system
By Products and Services
- Reagents and Consumables
- Instruments
- Cell Analyzers
-
- High-range
- Mid-range
- Low-range
- Cell Sorters
-
- High-range
- Mid-range
- Low-range
- Services
- Software
- Accessories
By Applications
- Research Applications
- Pharmaceuticals and Biotechnology
- Drug Discovery
- Stem Cell Research
- In vitro toxicity testing
- Immunology
- Cell Sorting
- Apoptosis
- Cell Cycle Analysis
- Cell Viability
- Cell Counting
- Other
- Clinical Applications
- Cancer Diagnostics
- Hematology
- Immunodeficiency Diseases
- Organ Transplantation
- Other Clinical Applications
By End-Users
- Commercial Organizations
- Hospitals
- Academic Institutes
- Clinical Testing Labs
By Region
- North America
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Russia
- Rest of the Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- UAE
- Rest of MEA
Key Market Players Profiled in the Report
- Danaher Corp
- Apogee Flow Systems
- Becton, Dickinson and Company
- BioMérieux S.A.
- Cytek Biosciences
- CytonomeST LLC
- Corning Incorporated
- Sartorius AG
- Enzo Life Sciences, Inc.
- GE Healthcare
- Luminex Corporation
- Agilent Technologies, Inc
- Bio-Rad Laboratories, Inc.
- Harvard Bioscience, Inc.
- Merck KGaA
- QIAGEN N.V.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- Sony Biotechnology Inc.
- Miltenyi Biotec
- Sysmex Corporation
- Stratedigm, Inc
Competitive Landscape
- Key players in the market include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Merck KGaA, Danahar Corporation, Agilent Technologies, Inc. These companies are considered manufacturers of flow cytometry system market based on their revenue, research development (R&D) activities, regional presence, and supply chain management system.
- The players are adopting key strategies such as acquisition, and geographical expansion where potential opportunity is added in the company’s capacity.
- For instance, In March 2020, Danaher Corp acquired Biopharma business of General Electric Company for customer base acquisition across the globe.
- In July 2019, BioMérieux S.A. acquired Invisible Sentinel, a US-based company specialized in food & beverage molecular testing for expanding business in North America.
Request For Customization
Enquiry Before Buying
Speak With Analyst
